NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 43 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is 5.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,000 | -28.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +16.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | -53.8% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $13,000 | -35.0% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $20,000 | -16.7% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $24,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|